Trial intelligence / Profile preview

Intranasal midazolam versus intranasal ketamine for neonatal intubation sedation in the delivery room

2011-003216-23Phase 3Completed

Sponsor
Centre Hospitalier Universitaire de Montpellier
Start
Sep 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of midazolam and ketamine in respiratory distress syndrome (RDS) (2 arms), sponsored by Centre Hospitalier Universitaire de Montpellier. Primary endpoint: Clinical pain score during intubation. Started Sep 2011; status: completed.

02

Drugs

midazolamketamine
03

Conditions

respiratory distress syndrome (RDS)

Beyond the preview

Go deeper on 2011-003216-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-003216-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call